Intensifying Diabetes Therapies to Achieve Personalized Treatment Goals-Therapeutics

Video Transcription

Video Summary

The video features Diana Isaacs, an endocrine clinical pharmacist and Director of Education and Training in Diabetes Technology at Cleveland Clinic in Cleveland, Ohio. In this video, she discusses intensifying diabetes treatment in a timely manner. She starts by outlining the learning objectives of the section, which include reviewing evidence-based guidelines on implementing complication-centric treatment options for type 2 diabetes and identifying methods to intensify therapies to reach timely glycemic targets while maintaining weight or promoting weight loss.<br /><br />Isaacs covers various topics in this section, including the goals for treatment, medication choices, cost considerations, and the use of diabetes technology. She highlights the importance of individualizing glycemic targets and considering factors such as hypoglycemia risk, age, comorbidities, resources, and patient preference. She also discusses the use of Continuous Glucose Monitoring (CGM) for behavior modification and medication adjustments. Isaacs provides insights into various medication options, including their efficacy for glucose lowering, impacts on cardiovascular disease and kidney disease, hypoglycemia risk, side effects, and cost considerations.<br /><br />Throughout the video, Isaacs refers to the guidelines provided by the American Diabetes Association (ADA) and the American Association of Clinical Endocrinology (ACE) to support treatment decisions. She also discusses cost-saving strategies and programs available to reduce medication costs for patients. Isaacs concludes with a case study, demonstrating how CGM can be used to adjust medication and achieve positive outcomes in a patient with type 2 diabetes.<br /><br />Please note that this summary is based on a transcription of the video content and does not include any additional visuals or presentation elements that may have been part of the original video.

Keywords

Diana Isaacs

intensifying diabetes treatment

glycemic targets

medication choices

Continuous Glucose Monitoring

CGM

cost considerations

American Diabetes Association